Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort

Experimental Dermatology

Volumn 20, Issue 10, 2011, Pages 848-850

  Mauerer, Andreas ^a   Herschberger, Eva ^a   Dietmaier, Wolfgang ^a   Landthaler, Michael ^a   Hafner, Christian ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cutaneous squamous cell carcinoma; EGFR; HRAS; Skin; Somatic mutation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RAS PROTEIN;

ADULT; AGED; CANCER INCIDENCE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GERMANY; HUMAN; HUMAN TISSUE; LETTER; MALE; ONCOGENE H RAS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENES, ERBB-1; GENES, RAS; GERMANY; HUMANS; MALE; MIDDLE AGED; MUTATION; SKIN NEOPLASMS;

EID: 80052960742     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01334.x     Document Type: Letter

References (27)

1. Garcia-Zuazaga J, Olbricht S M. Adv Dermatol 2008: 24: 33-57.
2. Boukamp P. Carcinogenesis 2005: 26: 1657-1667.
3. Fogarty G B, Conus N M, Chu J et al. Br J Dermatol 2007: 156: 92-98.
4. Toll A, Salgado R, Yebenes M et al. Exp Dermatol 2009: 19: 151-153.
5. Dahlhoff M, Rose C, Wolf E et al. Exp Dermatol 2011: 20: 290-293.
6. Suen J K, Bressler L, Shord S S et al. Anticancer Drugs 2007: 18: 827-829.
7. Jalili A, Pinc A, Pieczkowski F et al. J Dtsch Dermatol Ges 2008: 6: 1066-1069.
8. Bauman J E, Eaton K D, Martins R G. Arch Dermatol 2007: 143: 889-892.
9. Zandi R, Larsen A B, Andersen P et al. Cell Signal 2007: 19: 2013-2023.
10. Chee C E, Sinicrope F A. Gastroenterol Clin North Am 2010: 39: 601-613.
11. Modjtahedi H, Essapen S. Anticancer Drugs 2009: 20: 851-855.
12. Chen P, Wang L, Liu B et al. Eur J Clin Pharmacol 2011: 67: 235-243.
13. Mok T S, Wu Y L, Thongprasert S et al. N Engl J Med 2009: 361: 947-957.
14. Hafner C, Landthaler M, Vogt T. Exp Dermatol 2010: 19: e222-e227.
15. Savic S, Tapia C, Grilli B et al. Br J Cancer 2008: 98: 154-160.
16. Kompier L C, Lurkin I, van der Aa M N et al. PLoS ONE 2010: 5: e13821.
17. Fukushima T, Favereaux A, Huang H et al. J Neuropathol Exp Neurol 2006: 65: 12-18.
18. Corominas M, Kamino H, Leon J et al. Proc Natl Acad Sci U S A 1989: 86: 6372-6376.
19. Lieu F M, Yamanishi K, Konishi K et al. Cancer Lett 1991: 59: 231-235.
20. van der Schroeff J G, Evers L M, Boot A J et al. J Invest Dermatol 1990: 94: 423-425.
21. Pierceall W E, Goldberg L H, Tainsky M A et al. Mol Carcinog 1991: 4: 196-202.
22. Campbell C, Quinn A G, Rees J L. Br J Dermatol 1993: 128: 111-114.
23. Zaravinos A, Kanellou P, Spandidos D A. Br J Dermatol 2010: 162: 325-331.
24. Ridd K, Bastian B C. J Invest Dermatol 2010: 130: 901-903.
25. Sheikh Ali M A, Gunduz M, Nagatsuka H et al. Cancer Sci 2008: 99: 1589-1594.
26. Hama T, Yuza Y, Saito Y et al. Oncologist 2009: 14: 900-908.
27. Hafner C, Toll A, Fernandez-Casado A et al. Proc Natl Acad Sci U S A 2010: 107: 20780-20785.